Patent · US Active

Human-mouse chimeric anti-CD147 antibody with non-fucosylated glycosylation

US9963506B2 · kind B2 · utility

2Cited by
1References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 7, 2015
Grant dateMay 8, 2018
Priority date
Expiry dateOct 7, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to a nucleotide sequence comprising the sequence of SEQ ID NO: 5, and/or sequence of SEQ ID NO: 6, vector and host cell line comprising the nucleotide. The present disclosure also relates to an antibody that binds to extracellular region of human CD147, wherein the antibody comprises a heavy chain variable region having the amino acid sequence of SEQ ID NO: 2, and/or a light chain variable region having the amino acid sequence of SEQ ID NO: 1, and the antibody contains a glycoform lacking both fucose residues and xylose residues, pharmaceutical composition comprising the antibody or fragment thereof, the method of producing the antibody or fragment thereof, and use of the pharmaceutical composition in treatment of CD147 expression-related diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.